Global ADME-Toxicology Testing Analysis Report 2023-2030: Increased Need to Check Late-Stage Drug Failures Drive Market Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "ADME-Toxicology Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global ADME-Toxicology Testing Market to Reach $17.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for ADME-Toxicology Testing estimated at US$7.7 Billion in the year 2022, is projected to reach a revised size of US$17.3 Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2022-2030.

Cell Culture, one of the segments analyzed in the report, is projected to record a 12.6% CAGR and reach US$8.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the High Throughput Screening segment is readjusted to a revised 7.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.8 Billion, While China is Forecast to Grow at 14% CAGR

The ADME-Toxicology Testing market in the U.S. is estimated at US$3.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 14% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 11.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.

Select Competitors

What`s New for 2023?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year

Key Topics Covered:

MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• ADME-Toxicology Testing - Global Key Competitors Percentage Market Share in 2022 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
• ADME-Tox : An Introduction
• A Prelude to ADME Toxicology Testing
• COVID-19 IMPACT ON ADME TOXICOLOGY TESTING MARKET
• Global Market Prospects and Growth Drivers
• Drug Makers Bet on ADME & Toxicology Testing to Improve Success Rate for Potential Drug Candidates
• Cell Culture Holds a Major Share of the Market
• North America and Europe Dominate, Asia-Pacific Witnesses Rapid Growth
• Competition
• Recent Market Activity

MARKET TRENDS & DRIVERS

• Increased Need to Check Late-Stage Drug Failures Drive Market Growth
• Steady Increase in Average Drug Development Cost and Efforts to Mitigate Late-Stage Drug Failure Rates Highlights the Role of ADME-Toxicology Testing: Average Cost of Drug Development (in US$ Billion) in the US since 1980s
• Impact of ADME-Tox Screening on New Drug Discovery
• actors Leading to Failure of Drugs in Phase III Clinical Trials: Percentage Breakdown of Number of Cases for Efficacy, Pharmacokinetics, Toxicity and Others
• Drug Withdrawals Due to Toxicity Issues (1990-early 2010s): Percentage Share Breakdown of Number of Drugs Withdrawn Due to Cardiotoxicity, Hepatotoxicity and Others
• Pharma Industry Renews Focus on Cost Optimization
• Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2011 through 2020
• New FDA Approvals (2010-2020): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals
• China and India: Hot Spots for R&D Investment
• World R&D Market by Geographic Region (2020): Percentage Breakdown of R&D Spending for Asia, Europe, Middle East & Africa, North America and South America
• Growth Momentum Shifts Away from In Vivo Technologies; In Vitro Technologies to Lead the Charge
• Growing Prominence of Cell-based Assays in Drug Discovery and ADME Analysis
• Global Cell-based Assays Market by Segment (2020): Percentage Share Breakdown of Value Sales for Consumables, Instruments, Software, and Services
• Global Market for Cell-based Assays by End-User (2020): Percentage Share Breakdown of Value Sales for Pharma & Biotech Companies, Government & Academic Institutes, CROs, and Others
• World Cell-based Assays Market by Application (2020): Percentage Breakdown of Revenue for ADME, Basic Research and Drug Discovery
• Major Types of Cell-Based HTS Assays for Drug Screening
• Cell-based Assays in HTS and UHTS
• Innovation in Screening Guarantees Success for Drug Discovery Programs
• High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays
• High Content Screening - Key Application Areas
• HCS Market Ripe with Growth Opportunity
• HCS vs. HTS
• Increasing Use of Cell-Based Assays over Other Methods in Toxicity Testing
• 3D Cell Culture Technology to Put a New Spin on In Vitro Cell Analyses
• CDER's DARS 2 - Microphysiological 3D Cell Culture Platforms as Drug Development Tools
• Rising Investment in Proteomics R&D Drive Cell-based Assays Market
• Automated Multiplexing Platforms Present Growth Opportunities
• Automation of Cell-based Assays: A Growing Trend
• In-Silico ADME Emerge as Compelling Drug Discovery & Development Tool
• Advantages of Using In Silico Approaches
• Personalized Treatments & Computational Tools: Intriguing Facets of ADME R&D ADME Pharmacogenomics to Power Personalized Treatments
• ADME Research & Emerging Computational Tools
• Omics Technology
• Adoption of Omics-based Technologies
• In Vitro 3D Organoid Models to Meet ADME-Toxicity Testing Needs
• Limitations of Traditional in vitro Cellular Models
• Organoids Technology - Advanced in vitro 3D Platforms for More Physiologically Relevant Modeling
• Stem Cells Exude Great Potential in Drug Toxicity Testing
• Global Market for Stem Cell-Assays
• Functional Assays: An Effective Way of Predicting Specific Toxic Effects
• GPCR Targets to Drive Growth in Functional Cell Assay Market
• Molecular Imaging and ADME
• Organ-on-a-Chip Technology Gains Momentum in ADME Toxicology Testing
• Technological Advancements in ADME Toxicology Testing

FOCUS ON SELECT PLAYERS (Total 79 Featured)

• Agilent Technologies, Inc.
• Beckman Coulter, Inc.
• BioreclamationIVT, LLC
• CompuDrug International, Inc.
• Cyprotex PLC.
• Eurofins ADME BIOANALYSES SAS
• Molecular Discovery Ltd.
• MultiCASE, Inc.
• PerkinElmer, Inc.
• Pharmaron, Inc.
• Promega Corporation
• Simulations Plus, Inc.
• Taconic Biosciences, Inc.
• Takara Bio Europe AB
• Tecan Group Ltd.
• Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/r0v6l8

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.